Archives: Questions And Answers
ResMed Inc. (RMD) appears to have recovered technically towards $35 per share.
Please advise what you think of ACL as well as today’s results (10.08.22), which the market clearly doesn’t like (so far, at least), and if there is a price or range at which you would enter the stock, including in light of the large upcoming dividend?
Hi James, Shawn and Team
Hi James,
CAJ seems to be showing some life lately. Can you provide updated views on CAJ please, including with respect to buying it, and potentially price targets at which to sell or reduce?
Why does the income portfolio holding not show the recent WDS shares allocated through the BHP share holding?
James,
Hi MM Team,